ACD/Labs launches ACD/Spectrus Platform at PITTCON 2014 ACD/Labs.

Despite the emergence of crucial informatics technologies like ELN, LIMS, and SDMS, experts have acknowledged a substantial gap remains in how they automatically catch data for reporting still, analysis, and decision-making, says Ryan Sasaki, Directory of Global Strategy at ACD/Labs. The ACD/Spectrus System is helping our clients improve and maintain R&D efficiency in a number of different markets and sub-disciplines. The Spectrus advancements will impact organizations that work in areas such as for example preformulation, extractables and leachables, DMPK , organic synthesis, and labs focused on impurity control, identification, and characterization..Reacting to today’s announcement, AVAC executive director Mitchell Warren said, ‘Of course, we are disappointed to hear these total results, since we always hope that such a trial will in actuality prove effectiveness. Yet we are confident that MDP 301, since it was therefore well implemented, provides vital information to greatly help communities and researchers move forward in the search for effective and safe microbicides.’ Although the product had looked promising in animal studies and in previously human research, the MDP 301 trial provided a clear solution that this product can not work.